ProtoMatch: a tool for analyzing high-density, sequential eye gaze and cursor protocols

ProtoMatch is a software tool for integrating and analyzing fixed-location and movement eye gaze and cursor data. It provides a comprehensive collection of protocol analysis tools that support sequential data analyses for eye fixations and scanpaths as well as for cursor “fixations” (dwells at one location) and “cursorpaths” (movements between locations). ProtoMatch is modularized software that integrates both eye gaze and cursor protocols into a unified stream of data and provides an assortment of filters and analyses. ProtoMatch subsumes basic analyses (i.e., fixation duration, number of fixations, etc.) and introduces a method of objectively computing the similarity between scanpaths or cursorpaths using sequence alignment. The combination of filters, basic analyses, and sequence alignment in ProtoMatch provides researchers with a versatile system for performing both confirmatory and exploratory sequential data analyses (Sanderson & Fisher, 1994).     

Cognitive compensations for blindness in children: an investigation using odour naming

Historically, blindness has been associated with compensation for the loss of vision by the other senses. However, research to date has focused on perceptual compensations, largely ignoring possible cognitive compensations. We explored the notion that cognitive skills of blind children may facilitate performance in apparently perceptual tasks, by investigating the cognitive factors related to naming a familiar odour. Eighty-three children participated in olfactory and cognitive tasks (thirty-two early-blind, five late-blind, fourteen low-vision, and thirty-two sighted). In the olfactory tasks, the early-blind children performed significantly better than the sighted children on the odour-naming task but not on the odour-sensitivity task. From the cognitive tasks, scores on a nonvisualisable word-pairs task and a sound-word-pairs task were significantly higher for early-blind children and were highly correlated with odour-naming score. The early-blind children outperformed the sighted controls on a task of directed attention. The groups did not differ on memory for a story or for visualisable word pairs. The results suggest that blind children enjoy an advantage in tasks that assess nonvisual memory for paired associates and directed attention, and that superiority on these tasks facilitates performance in the odour-naming task. Other data suggest that sighted children rely on visualisation as a strategy to aid their performance on the cognitive tasks, and are disadvantaged when these strategies cannot be utilised.     

Core mechanisms in "theory of mind"

Our ability to understand the thoughts and feelings of other people does not initially develop as a theory but as a mechanism. The "theory of mind" mechanism (ToMM) is part of the core architecture of the human brain, and is specialized for learning about mental states. Impaired development of this mechanism can have drastic effects on social learning, seen most strikingly in the autistic spectrum disorders. ToMM kick-starts belief-desire attribution but effective reasoning about belief contents depends on a process of selection by inhibition. This selection process (SP) develops slowly through the preschool period and well beyond. By modeling the ToMM-SP as mechanisms of selective attention, we have uncovered new empirical phenomena. We propose that early "theory of mind" is a modular-heuristic process of domain-specific learning.     

Visual skills in airport-security screening

Abstract— An experiment examined visual performance in a simulated luggage-screening task. Observers participated in five sessions of a task requiring them to search for knives hidden in x-ray images of cluttered bags. Sensitivity and response times improved reliably as a result of practice. Eye movement data revealed that sensitivity increases were produced entirely by changes in observers' ability to recognize target objects, and not by changes in the effectiveness of visual scanning. Moreover, recognition skills were in part stimulus-specific, such that performance was degraded by the introduction of unfamiliar target objects. Implications for screener training are discussed.     

Handedness and the fringe of consciousness: strong handers ruminate while mixed handers self-reflect

Previous research found that mixed handers (i.e., those that are more ambidextrous) were more likely than strong handers to update their beliefs (Niebauer, Aselage, & Schutte, 2002). It was assumed that this was due to greater degrees of communication between the two cerebral hemispheres in mixed handers. Niebauer and Garvey (2004) made connections between this model of updating beliefs and metacognitive processing. The current work proposes that variations in interhemispheric interaction (as measured by degree of handedness) contribute to differences in consciousness, specifically when consciousness is used in rumination versus the metacognitive task of self-reflection. Using the Rumination-Reflection Questionnaire (Trapnell & Campbell, 1999), predictions were supported such that strong handedness was associated with self-rumination; whereas, mixed handedness was associated with increased self-reflection p values<.01, (N=255). James's (1890) concept of the "fringe of consciousness" is used to make connections between metacognition, updating beliefs, and self-reflection. Several studies are reviewed suggesting that mixed handers experience fringe consciousness to a greater degree than strong handers.     

The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease

Alzheimer's disease is a progressive, neurodegenerative condition characterized by deficits in cognition, inability to perform activities of daily living, and alterations in behavior. Galantamine hydrobromide is the newest acetylcholinesterase inhibitor (AChEI) approved in the United States for the treatment of mild-to-moderate AD. The safety and efficacy of galantamine has been demonstrated in multiple randomized, Phase III trials of >2,600 patients with mild-to-moderate AD. Studies have found that galantamine improved or maintained performance in all domains of AD (cognition, function, behavior, and caregiver burden) in the short term and slowed the decline in performance or maintained baseline performance through 12 months. The dual mechanism of action may make galantamine a reasonable treatment option for both newly diagnosed patients and patients who have not benefitted from or have poorly tolerated current therapy.     

Treatment-resistant posttraumatic stress disorder: strategies for intervention

The mainstay of treatment for chronic posttraumatic stress disorder (PTSD) is a combination of psychotherapy and medication treatments. The first-line medications for PTSD are antidepressants, with two selective serotonin reuptake inhibitors (sertraline and paroxetine) currently Food and Drug Administration-indicated for PTSD. However, many patients do not have an adequate response to antidepressants, therefore, combinations with other antidepressants or with other classes of psychotropic medication are often utilized to enhance the therapeutic response. Other agents that have been used include mood stabilizers, anti-adrenergics, anxiolytics, and atypical antipsychotics. The heterogeneity of symptom clusters in PTSD as well as the complex psychiatric comorbidities (eg, with depression or substance abuse) further support the notion that combinations of medications may be needed. To date, there is a paucity of data to support specific strategies for augmenting antidepressants in PTSD. This review will address representative existing studies and discuss several potential pharmacologic strategies for patients suffering from treatment-refractory PTSD.